Clinical Trial 53713

Scottsdale, AZ 85260


Summary:

A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of Vaccine Antibody Response in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD).


Qualified Participants Must:

• Be 18 years of age
• Diagnosed with Atopic Dermatitis for at least 6 months
• Have at least 7% of their body affected by the condition


Qualified Participants May Receive:

  • Up to $3300
  • Free medication
  • free lab work


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.